Dr Datsons Labs Ltd

6.40+0.0 (+0.00%)

1 Jun, 12:00 AM

Income Statement

Abridged

Understanding Income Statement

Dr Datsons Labs Ltd income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31
	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR
Total Revenue	-	21.88	90.13	161.67	320.26	479.96	520.76	421.05
Cost of Operating Revenue	-	16.72	76.29	127.40	240.58	377.98	416.43	376.65
Gross Profit	-	5.16	13.84	34.27	79.68	101.98	104.33	44.41
Gross Margin	-	23.6	15.4	21.2	24.9	21.2	20.0	10.5
Total Operating Expenses	-	17.39	79.76	133.28	251.87	390.26	435.31	384.81
Operating Profit	-	4.49	10.38	28.39	68.39	89.70	85.45	36.24
Operating Margin	-	20.5	11.5	17.6	21.4	18.7	16.4	8.6
Financing Income/(Expense) - Net	-	-0.78	-2.57	-5.99	-13.87	-27.37	-38.02	-35.17
Profit before Taxes	-	3.71	7.81	22.88	54.65	63.01	2.65	1.09
Income Taxes	-	0.01	0.05	7.78	18.58	22.02	2.22	0.61
Profit after Tax	-	3.70	7.76	15.10	36.07	40.99	0.43	0.48
PAT Margin	-	16.9	8.6	9.3	11.3	8.5	0.1	0.1
EPS - Basic - ex Extraordinary Items	-0.03	1.84	4.04	11.99	28.63	34.38	0.31	0.33
EPS - Diluted - ex Extraordinary Items	-0.03	1.84	4.04	11.99	28.63	34.38	0.31	0.33
EBIT	-	4.49	10.38	28.39	68.39	89.70	85.45	36.24
EBITDA	-	4.71	10.90	29.27	70.98	105.38	105.67	56.68
EBITDA Margin	-	21.5	12.1	18.1	22.2	22.0	20.3	13.5

Balance Sheet

Abridged

Understanding Balance Sheet

Dr Datsons Labs Ltd balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31
	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31	C 2012 Mar 31	2013 Mar 31	2014 Mar 31
Source:	PR	PR	PR	PR	AR	AR	AR	AR
Total Current Assets	0	17	47	84	178	360	672	685
Long-Term Investments	0	0	0	0	0	0	0	210
Property Plant & Equipment - Net	1	11	14	51	117	358	373	367
Total Non-Current Assets	1	11	14	51	117	358	373	578
Total Assets	1	28	61	135	295	718	1,045	1,263
Total Current Liabilities	0	10	10	23	17	252	360	671
Long Term Debt	1	12	38	60	139	101	359	167
Total Non-Current Liabilities	1	13	39	62	144	116	376	184
Total Liabilities	1	23	48	85	160	368	736	856
Total Shareholders' Equity	0	4	12	50	134	350	309	408
Minority Interest	-	-	-	-	-	0	-	-
Total Equity	0	4	12	50	134	350	309	408
Total Liabilities & Equity	1	28	61	135	295	718	1,045	1,263

Cash Flow

Abridged

Understanding Cash Flow Statement

Dr Datsons Labs Ltd cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2007 Mar 31	2008 Mar 31	2009 Mar 31	C 2010 Mar 31	2011 Mar 31	2013 Mar 31	2014 Mar 31
	2007 Mar 31	2008 Mar 31	2009 Mar 31	C 2010 Mar 31	2011 Mar 31	2013 Mar 31	2014 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	-	4.28	7.69	21.36	55.17	70.07	-190.00
Working Capital - Increase/(Decrease)	0.13	-7.40	-32.21	-26.81	-114.53	-74.51	71.09
Net CF from Operating Activities	0.13	-3.12	-24.51	-5.45	-59.35	-4.44	-118.91
Capital Expenditures - Net	0.67	10.30	2.98	38.80	68.48	34.68	15.19
Net CF from Investing Activities	-0.67	-10.70	-2.98	-38.80	-68.48	-34.68	-15.19
Dividends Paid - Cash - Total	-	-	-	-	-	3.39	-
Stock - Issuance/(Retirement) - Net	0.01	1.99	2.95	0.83	1.80	-	17.77
Debt - LT & ST - Issuance/(Retirement) - Total	0.54	11.90	25.19	21.96	79.15	251.44	-174.69
Net Cash Flow from Financing Activities	0.55	13.89	28.14	44.28	127.75	247.18	-76.96
Free Cash Flow to Equity	0.00	-1.52	-2.30	-22.29	-48.69	212.32	-308.79
Free Operating CF net dividend	-0.54	-13.42	-27.49	-44.25	-127.84	-42.51	-134.10
Free Operating CF	-0.54	-13.42	-27.49	-44.25	-127.84	-39.12	-134.10

Business Segment Analysis

FY End:

Mar 11

Dr Datsons Labs Ltd business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

API (57.8%)₹ 39.61 CrFormulation (42.0%)₹ 28.76 CrUnallocable (0.2%)₹ 0.11 Cr

Revenue / Sales

API (58.9%)₹ 188.60 CrFormulation (40.9%)₹ 130.97 CrUnallocable (0.2%)₹ 0.70 Cr

Assets

API (59.5%)₹ 175.60 CrFormulation (38.5%)₹ 113.46 CrUnallocable (2.0%)₹ 5.82 Cr

Regional Segment Analysis

Dr Datsons Labs Ltd geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Dr Datsons Labs Ltd

Historical Segment Analysis

Track how Dr Datsons Labs Ltd segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Business

Regional

Business

	2011 Mar 31
	2011 Mar 31
API	40
Formulation	29
Unallocable	0

Frequently Asked Questions

What is the revenue of Dr Datsons Labs Ltd?

The latest trailing twelve month revenue of Dr Datsons Labs Ltd is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Dr Datsons Labs Ltd?

The latest trailing twelve month net profit (PAT) of Dr Datsons Labs Ltd is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Dr Datsons Labs Ltd?

The operating margin of Dr Datsons Labs Ltd is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Dr Datsons Labs Ltd?

The trailing twelve month Earnings Per Share (EPS) of Dr Datsons Labs Ltd is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Dr Datsons Labs Ltd?

The debt-to-equity ratio of Dr Datsons Labs Ltd stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Dr Datsons Labs Ltd?

The book value per share of Dr Datsons Labs Ltd is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Dr Datsons Labs Ltd?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Dr Datsons Labs Ltd report consolidated or standalone financials?

Dr Datsons Labs Ltd reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.